152 related articles for article (PubMed ID: 4111108)
41. Regression of diffuse B-cell lymphoma of the leg with intralesional gentian violet.
Rao S; Morris R; Rice ZP; Arbiser JL
Exp Dermatol; 2018 Jan; 27(1):93-95. PubMed ID: 28833549
[TBL] [Abstract][Full Text] [Related]
42. Diaper dye dermatitis.
Alberta L; Sweeney SM; Wiss K
Pediatrics; 2005 Sep; 116(3):e450-2. PubMed ID: 16140691
[TBL] [Abstract][Full Text] [Related]
43. Candidal vulvovaginitis treatment with a new non-staining, non-messy gentian violet.
KARNAKY KJ
Ariz Med; 1958 Aug; 15(8):578-81. PubMed ID: 13560272
[No Abstract] [Full Text] [Related]
44. Targeted therapy of oral hairy leukoplakia with gentian violet.
Bhandarkar SS; MacKelfresh J; Fried L; Arbiser JL
J Am Acad Dermatol; 2008 Apr; 58(4):711-2. PubMed ID: 18342722
[TBL] [Abstract][Full Text] [Related]
45. Formation of mucous membrane lesions secondary to prolonged use of one per cent aqueous gentian violet.
SLOTKOWSKI EL
J Pediatr; 1957 Dec; 51(6):652-4. PubMed ID: 13481803
[No Abstract] [Full Text] [Related]
46. The treatment of skin diseases in childhood.
Morley N
Practitioner; 1970 Jan; 204(219):97-108. PubMed ID: 4243744
[No Abstract] [Full Text] [Related]
47. [ON THE EFFECT OF SOME DIFFERENT ANTIECZEMA AGENTS ON THE NORMAL GUINEA PIG SKIN. II. DYES].
SALFELD K; ORTH F
Arch Klin Exp Dermatol; 1965 Feb; 221():383-93. PubMed ID: 14262141
[No Abstract] [Full Text] [Related]
48. Gentian violet and thrush.
Utter AR
J Hum Lact; 1992 Mar; 8(1):6. PubMed ID: 1558661
[No Abstract] [Full Text] [Related]
49. Management of the umbilicus with crystal violet solution.
Bale MS
Can Med Assoc J; 1981 Feb; 124(4):372-3. PubMed ID: 7214266
[No Abstract] [Full Text] [Related]
50. Gentian violet in the treatment of oral candidiasis.
Leung AK
Pediatr Infect Dis J; 1988 Apr; 7(4):304-5. PubMed ID: 3368270
[No Abstract] [Full Text] [Related]
51. The role of topical medications in the management of stasis ulcers.
Fisher AA
Angiology; 1971 Apr; 22(4):206-10. PubMed ID: 4396955
[No Abstract] [Full Text] [Related]
52. "Timodine" cream in the treatment of flexural dermatoses and napkin rash.
Almeyda JJ; Feiwel M; Thorne N; Vickers CF
Practitioner; 1974 Dec; 213(1278):864-7. PubMed ID: 4282136
[No Abstract] [Full Text] [Related]
53. Gentian violet toxicity.
Piatt JP; Bergeson PS
Clin Pediatr (Phila); 1992 Dec; 31(12):756-7. PubMed ID: 1451385
[No Abstract] [Full Text] [Related]
54. Diaper rash--may be due to colored dyes in diapers.
Child Health Alert; 2005 Oct; 23():3. PubMed ID: 16294376
[No Abstract] [Full Text] [Related]
55. [The detection of Brilliant Green in cadaveric material].
Murav'eva GM
Sud Med Ekspert; 1999; 42(3):35-6. PubMed ID: 10396967
[No Abstract] [Full Text] [Related]
56. Growth inhibition of Bacillus subtilis by basic dyes.
Ogawa T; Shibata M; Yatome C; Idaka E
Bull Environ Contam Toxicol; 1988 Apr; 40(4):545-52. PubMed ID: 2453237
[No Abstract] [Full Text] [Related]
57. Occlusive laryngotracheitis in turkeys following drinking water administration of gentian violet.
Clark FD; Frame DD; Jensen MM
Avian Dis; 1993; 37(1):226-8. PubMed ID: 8452501
[TBL] [Abstract][Full Text] [Related]
58. [The photometric determination of brilliant green].
Papke E
Pharmazie; 1978 Jan; 33(1):86. PubMed ID: 674290
[No Abstract] [Full Text] [Related]
59. Descemet-stripping automated endothelial keratoplasty (DSAEK): effect of nontoxic gentian violet marking pen on DSAEK donor tissue viability by using vital dye assay.
Ide T; Yoo SH; Kymionis GD; Perez VL; Goldman JM; O'Brien TP
Cornea; 2008 Jun; 27(5):562-4. PubMed ID: 18520506
[TBL] [Abstract][Full Text] [Related]
60. Anterior capsule staining for capsulorhexis in cases of white cataract: comparative clinical study.
Dada VK; Sharma N; Sudan R; Sethi H; Dada T; Pangtey MS
J Cataract Refract Surg; 2004 Feb; 30(2):326-33. PubMed ID: 15030820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
